Takeshita, Akihiro <br/><br/>
Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study.  [electronic resource] 

 -  Leukemia  02 2019 
 - 358-370 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/s41375-018-0233-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Benzoates--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Leukemia, Promyelocytic, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prospective Studies<br/>Remission Induction<br/>Salvage Therapy<br/>Survival Rate<br/>Tetrahydronaphthalenes--therapeutic use<br/>Young Adult